Categories: Events

Binaytara Foundation’s Annual Fundraising Gala to be held on April 30, 2022

The Binaytara Foundation’s Annual Fundraising gala benefiting the Binaytara Foundation Cancer Center, a 25-bed cancer hospital in Nepal’s Province 2, will be held on April 30th, 2022 at the Grand Hyatt Seattle located in Downtown Seattle. This fundraising gala will take place during the time of the 2022 Summit on Cancer Health Disparities – also happening at the same venue from April 29th, 2022 to May 1, 2022.


What: Fundraising Gala

Where: Grand Hyatt Seattle, WA

When: April 30th 2022 at 6:30 PM

Why: To support the construction of a 200-bed cancer hospital in Nepal. Learn more about the cancer hospital here.

Who: You, the human who cares about another human and wants to make a difference in their lives.


Approximately 200 supporters, including several oncology professionals, individuals from the Nepali diaspora, local puget sound supporters, and others are expected to join the 2022 fundraiser. The funds will go towards building the boundary wall around the recently purchased land in Janakpur, Nepal where the new cancer hospital campus will be located. Several local businesses and individual donors have donated items for the silent auction which include museum tickets, restaurant gift cards, adventure passes, one of a kind jewelry pieces, and wine tasting, among others.

The dress code for this Nepal-themed fundraiser evening is semi-formal and the agenda will include silent auctions, live auctions, performances by artists, and paddle raise. Please save the date for this special evening to support a cause that will save thousands of lives.

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

5 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

5 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago